title: Nucleotide variations in the 3' A gamma enhancer region are linked to beta-gene cluster haplotypes and are unrelated to fetal hemoglobin expression.
abstract: Molecular cloning and sequence analysis of a nondeletion form of Sicilian beta o hereditary persistence of fetal hemoglobinemia (HPFH) (mutation in IVS2 nt1 position) homozygous for haplotype III revealed the presence of four sequence variations: C----T at -158 5' to G gamma, T----C at +2285, C----A at +2476, and A----G at +2676, all 3' to A gamma. The latter three variations in the putative A gamma enhancer are identical to those observed in the case of Seattle HPFH. However, a severe beta o-thalassemia case from Algeria (mutation in IVS1 nt1 position), also homozygous for haplotype III, revealed the same nucleotide variation, albeit an inefficient HbF production. We conclude that the variations in the A gamma enhancer element do not play a role in the regulation of HbF production. To assess both the linkage of these sites with the beta-cluster haplotype and the extent of the polymorphism, we examined several black and Mediterranean chromosomes, by PCR amplification followed by both EspI digestion and oligonucleotide hybridization. Our data indicate that these sequence variations in the enhancer element are absent in Mediterranean haplotypes I, V, and VII but are consistently associated with Mediterranean haplotypes II, III, and IX, as well as with the black beta c-associated haplotype. The common feature of all the latter haplotypes is the presence of a polymorphic PvuII site between A gamma and psi beta, which is thus in linkage disequilibrium with the variations in the A gamma enhancer.(ABSTRACT TRUNCATED AT 250 WORDS)
authors: INSERM, Paris.
authors: A
authors: A
authors: Ragusa
authors: M
authors: M
authors: Lombardo
authors: E
authors: E
authors: Bouhassira
authors: C
authors: C
authors: Beldjord
authors: T
authors: T
authors: Lombardo
authors: R L
authors: RL
authors: Nagel
authors: D
authors: D
authors: Labie
authors: R
authors: R
authors: Krishnamoorthy
mesh_terms: D001483:Base Sequence; D002648:Child; D003001:Cloning, Molecular; D015252:Deoxyribonucleases, Type II Site-Specific; D004742:Enhancer Elements, Genetic; D005260:Female; D005319:Fetal Hemoglobin / Q000235:genetics*; D005796:Genes; D008040:Genetic Linkage; D014644:Genetic Variation; D006239:Haplotypes; D006453:Hemoglobinopathies / Q000097:blood / Q000235:genetics*; D006801:Humans; D046911:Macromolecular Substances; D008297:Male; D008969:Molecular Sequence Data; D005810:Multigene Family; D010375:Pedigree; D012150:Polymorphism, Restriction Fragment Length; D015183:Restriction Mapping; D013789:Thalassemia / Q000097:blood / Q000235:genetics
chemical_list: D046911:Macromolecular Substances; D005319:Fetal Hemoglobin; C025630:CAGCTG-specific type II deoxyribonucleases; D015252:Deoxyribonucleases, Type II Site-Specific